Documents  Eric Van Cutsem, 1 Cathy Eng, 2 Josep Tabernero, 3 Elzbieta Nowara, 4 Anna Świeboda-Sadlej, 5

A Randomized, Phase 1/2 Trial of AMG 102 or AMG 479 in Combination With Panitumumab vs Panitumumab Alone in Patients With Wild‑Type KRAS Metastatic Colorectal Cancer (mCRC):…